Wave Life Sciences Statistics Share Statistics Wave Life Sciences has 159.14M
shares outstanding. The number of shares has increased by 20.37%
in one year.
Shares Outstanding 159.14M Shares Change (YoY) 20.37% Shares Change (QoQ) 0.42% Owned by Institutions (%) 80.8% Shares Floating 127.12M Failed to Deliver (FTD) Shares 425 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 16.41M, so 10.55% of the outstanding
shares have been sold short.
Short Interest 16.41M Short % of Shares Out 10.55% Short % of Float 14.39% Short Ratio (days to cover) 12.3
Valuation Ratios The PE ratio is -17.63 and the forward
PE ratio is -6.86.
Wave Life Sciences's PEG ratio is
-0.6.
PE Ratio -17.63 Forward PE -6.86 PS Ratio 15.79 Forward PS 24.2 PB Ratio 8.16 P/FCF Ratio -11.26 PEG Ratio -0.6
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Wave Life Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.89,
with a Debt / Equity ratio of 0.12.
Current Ratio 2.89 Quick Ratio 2.89 Debt / Equity 0.12 Debt / EBITDA -0.25 Debt / FCF -0.17 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $377.36K Profits Per Employee $-338.01K Employee Count 287 Asset Turnover 0.31 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 51.02% in the
last 52 weeks. The beta is -0.96, so Wave Life Sciences's
price volatility has been lower than the market average.
Beta -0.96 52-Week Price Change 51.02% 50-Day Moving Average 7.42 200-Day Moving Average 10.02 Relative Strength Index (RSI) 51.54 Average Volume (20 Days) 1,330,658
Income Statement In the last 12 months, Wave Life Sciences had revenue of 108.3M
and earned -97.01M
in profits. Earnings per share was -0.7.
Revenue 108.3M Gross Profit 108.3M Operating Income -110.4M Net Income -97.01M EBITDA -101.74M EBIT -110.4M Earnings Per Share (EPS) -0.7
Full Income Statement Balance Sheet The company has 302.08M in cash and 25.4M in
debt, giving a net cash position of 276.67M.
Cash & Cash Equivalents 302.08M Total Debt 25.4M Net Cash 276.67M Retained Earnings -1.12B Total Assets 252.35M Working Capital 136.15M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -151.03M
and capital expenditures -938K, giving a free cash flow of -151.96M.
Operating Cash Flow -151.03M Capital Expenditures -938K Free Cash Flow -151.96M FCF Per Share -1.1
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -101.94% and -89.57%.
Gross Margin 100% Operating Margin -101.94% Pretax Margin -89.57% Profit Margin -89.57% EBITDA Margin -93.94% EBIT Margin -101.94% FCF Margin -140.32%
